Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Exchange Rate Effect data on record, last reported at $17000.0 in Q1 2013.

  • For Q1 2013, Exchange Rate Effect rose 158.62% year-over-year to $17000.0; the TTM value through Mar 2013 reached $19000.0, up 124.68%, while the annual FY2025 figure was -$616000.0, 2025.0% down from the prior year.
  • Exchange Rate Effect reached $17000.0 in Q1 2013 per SNOA's latest filing, up from $4000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $23000.0 in Q3 2010 and bottomed at -$58000.0 in Q3 2011.
  • Average Exchange Rate Effect over 4 years is -$3000.0, with a median of $3000.0 recorded in 2011.
  • Peak YoY movement for Exchange Rate Effect: surged 180.0% in 2011, then tumbled 1100.0% in 2012.
  • A 4-year view of Exchange Rate Effect shows it stood at -$10000.0 in 2010, then surged by 180.0% to $8000.0 in 2011, then tumbled by 50.0% to $4000.0 in 2012, then soared by 325.0% to $17000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $17000.0 in Q1 2013, $4000.0 in Q4 2012, and $18000.0 in Q3 2012.